Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New approach to replacing immune cells shrink tumors in patients with melanoma

20.09.2002


A new approach to cancer treatment that replaces a patient’s immune system with cancer-fighting cells can lead to tumor shrinkage, researchers report today in the journal Science*. The study demonstrates that immune cells, activated in the laboratory against patients’ tumors and then administered to those patients, can attack cancer cells in the body.



The experimental technique, known as adoptive transfer, has shown promising results in patients with metastatic melanoma who have not responded to standard treatment. With further research, scientists hope this approach may have applications to many cancer types, as well as infectious diseases such as AIDS.

In the study, 13 patients with metastatic melanoma (a deadly form of skin cancer) who had not responded to standard treatments were treated with immune cells produced in the laboratory specifically to destroy their tumors. The treatment resulted in at least 50 percent tumor shrinkage in six of the patients, with no growth or appearance of new tumors. Four additional patients had some cancer growths disappear.


Researchers have tried previously to treat cancer with immune cells but the cells did not survive well in the body. "In the past, only a fraction of a percent of the cells we injected were able to survive, and they would persist for only a few days," said Steven A. Rosenberg, M.D., Ph.D., of the National Cancer Institute, the lead researcher on the study.

Improvements in the way immune cells are generated in the laboratory and the way patients’ bodies are prepared to receive them, however, have led to dramatically different results. "We have been able to generate a very large number of immune cells that appear in the blood and constitute a majority of the immune system of the patient. These persist for over four months and are able to attack the tumor," Rosenberg said.

The adoptive transfer technique fights cancer with T cells, immune cells that recognize and kill foreign cells that have invaded the body. Researchers used a small fragment of each patient’s melanoma tumor to grow T cells in the laboratory, using T cells originally taken from the patients. Exposure to the tumor activated the immune cells so that they would recognize and attack cells from each specific cancer.

Once the T cells had multiplied to a sufficient number to be used for treatment, they were administered to patients. Patients were also given a high dose of a protein called interleukin-2 (IL-2), which stimulates continued T cell growth in the body. Prior to the immunotherapy, chemotherapy had been used to deplete patients’ own immune cells, which had proven ineffective at fighting the cancer. Diminishing the old cells provided an opportunity for the new T cells to repopulate patients’ immune systems. Analysis of blood and tumor samples from many of the patients who responded favorably to the treatment revealed that the administered immune cells were thriving, multiplying rapidly, and attacking tumor tissue. T cells activated against melanoma became the major component in patients’ immune systems. They persisted for several months and were able to destroy metastases throughout the body.

Over time, patients’ old immune systems recovered, restoring their ability to fight infections. Researchers report that among the patients in the study, only occasional opportunistic infections developed during treatment.

Other side effects were mild autoimmune disorders. T cells act by recognizing a protein fragment called an antigen on the outside of the tumor cells. Antigens found on tumor cells may also be found on certain normal cells in the body, making them vulnerable to attack. Autoimmune effects among the patients in the study were mild and easily controlled.

Although the treatment is highly experimental, researchers are optimistic that it may, in the future, extend beyond the treatment of patients with melanoma. It should be possible, they say, to raise immune cells that will recognize and attack many tumor types.

Similarly, the same technique could potentially be used to treat some infectious diseases, such as AIDS.

NCI Press Office | EurekAlert!
Further information:
http://www.cancer.gov

More articles from Health and Medicine:

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

nachricht Highly precise wiring in the Cerebral Cortex
21.09.2017 | Max-Planck-Institut für Hirnforschung

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>